Israel Englander Bridge Bio Pharma, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 37,472 shares of BBIO stock, worth $888,835. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,472

Previous 241,780 84.5%

Holding current value

$888,835

Previous $6.12 Million 84.42%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$23.91 - $31.3 $4.89 Million - $6.39 Million	-204,308 Reduced 84.5%	37,472 $954,000
Q2 2024 Aug 14, 2024	BUY	$23.0 - $31.04 $2.88 Million - $3.89 Million	125,178 Added 107.35%	241,780 $6.12 Million
Q1 2024 May 15, 2024	BUY	$27.35 - $40.45 $1.66 Million - $2.46 Million	60,839 Added 109.1%	116,602 $3.61 Million
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $1.34 Million - $2.45 Million	55,763 New	55,763 $2.25 Million
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $1.62 Million - $4.2 Million	226,392 Added 268.95%	310,569 $5.15 Million
Q4 2022 Feb 14, 2023	SELL	$6.74 - $11.52 $7.29 Million - $12.5 Million	-1,081,131 Reduced 92.78%	84,177 $641,000
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $4.47 Million - $6.96 Million	563,441 Added 93.62%	1,165,308 $11.6 Million
Q2 2022 Aug 15, 2022	SELL	$5.21 - $12.14 $1.65 Million - $3.84 Million	-315,942 Reduced 34.42%	601,867 $5.47 Million
Q1 2022 May 16, 2022	SELL	$7.34 - $17.16 $4.24 Million - $9.92 Million	-578,264 Reduced 38.65%	917,809 $9.32 Million
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $14.3 Million - $67.2 Million	1,258,858 Added 530.68%	1,496,073 $25 Million
Q3 2021 Nov 15, 2021	BUY	$46.87 - $64.24 $4.51 Million - $6.18 Million	96,204 Added 68.22%	237,215 $11.1 Million
Q2 2021 Aug 16, 2021	BUY	$46.47 - $63.93 $4.61 Million - $6.34 Million	99,169 Added 237.01%	141,011 $8.6 Million
Q1 2021 May 17, 2021	SELL	$55.47 - $72.35 $2.86 Million - $3.73 Million	-51,600 Reduced 55.22%	41,842 $2.58 Million
Q4 2020 Feb 16, 2021	BUY	$38.38 - $71.11 $3.59 Million - $6.64 Million	93,442 New	93,442 $6.65 Million
Q3 2020 Nov 16, 2020	SELL	$27.2 - $42.19 $1.08 Million - $1.67 Million	-39,680 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$22.22 - $35.69 $4.37 Million - $7.01 Million	-196,520 Reduced 83.2%	39,680 $1.29 Million
Q1 2020 May 14, 2020	BUY	$16.11 - $36.23 $3.81 Million - $8.56 Million	236,200 New	236,200 $6.85 Million
Q4 2019 Feb 14, 2020	SELL	$17.96 - $46.63 $671,380 - $1.74 Million	-37,382 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$20.13 - $32.38 $6.9 Million - $11.1 Million	-342,537 Reduced 90.16%	37,382 $802,000
Q2 2019 Aug 14, 2019	BUY	$26.97 - $27.55 $10.2 Million - $10.5 Million	379,919 New	379,919 $10.2 Million

Others Institutions Holding BBIO

# of Institutions

291

Shares Held

171M

Call Options Held

10.4M

Put Options Held

2.37M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.52B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account